COVID-19 Top Headlines

A curated list of the top COVID-19 headlines from news organizations and industry publications.

• 1/25/22: Free N95 Masks Now Available at Some US Pharmacy Locations, Wider Rollout Expected Soon (WaPo)

• 1/18/22: Biden Admin Makes Free COVID-19 Rapid Tests Available Thru New Website (CNN)

• 1/13/22: Supreme Court Blocks Vaccine Mandate for Large Employers (NY Times)

• 1/10/22: New Guidance Requires Insurers to Cover 8 At-Home COVID Tests Per Month (NY Times)

• 1/3/22: FDA Authorizes Pfizer Booster Doses for Children Ages 12-15 (NY Times)

• 1/1/22: COVAX Deliveries Surged in December, but Falls Short of 2021 Goal (WaPo)

• 12/22/21: FDA Approves First At-Home COVID-19 Treatment (AP)

• 12/20/21: Pharmacists Experiencing Burnout Amid COVID Surge (WSJ)

• 12/16/21: CDC Recommends Pfizer and Moderna Vaccines Over J&J Due to Rare Clotting Issue (CNN)

• 12/2/21: Biden Admin Releases Winter COVID Strategy, Including Insurance Coverage of At-Home Tests (WaPo)

• 11/30/21: FDA Advisory Panel Recommends Emergency Authorization of COVID-19 Antiviral Molnupiravir (NY Times)

• 11/29/21: CDC Recommends All Adults Receive COVID-19 Booster (The Hill)

• 11/22/21: Admin Announces $1.5B from COVID-19 Aid Package to Help Address Healthcare Worker Shortage (AP)

• 11/17/21: Admin Announces Initiative to Boost Global Production of mRNA COVID-19 Vaccines (AP)

• 11/12/21: Federal Appeals Court Stays OSHA Vaccine Requirements Pending Challenge (NY Times)

• 11/6/21: Fifth Circuit Suspends Employer Vaccine and Testing Rule (NY Times)

• 11/4/21: Biden Admin Sets Jan. 4 Vaccination Deadline for Large Employers (NY Times)

• 11/2/21: CDC Recommends COVID-19 Vaccine for Children Aged 5-11, Rollout to Begin Next Week (USA Today)

• 10/20/21: FDA Authorizes Moderna and J&J Booster Shots and Mix-and-Match Strategy (NY Times)

• 10/18/21: US Will Finance COVID-19 Vaccine Plants Overseas (NPR)

• 10/14/21: FDA Panel Will Review Oral COVID-19 Antiviral Drug on November 30 (Reuters)

• 10/12/21: Biden Admin Allocates $1 Billion to Boost Rapid At-Home COVID-19 Tests (Fox)

• 9/23/21: FDA Authorizes Booster Shots for Older and At-Risk Americans (NY Times)

• 9/18/21: KFF Finds Insurers Asking Unvaccinated People to Share Cost of COVID-19 Treatment (WaPo)

• 9/14/21: Biden Administration Takes Over Distribution of COVID-19 Therapies and Purchases More Doses (CNN)

• 9/13/21: HHS Amends PREP Act to Allow Pharmacists to Administer Some COVID-19 Therapeutics (Becker's Hospital Review)

• 9/10/21: HHS Announces $25 Billion in COVID-19 Provider Relief Grants (Modern Healthcare)

• 9/9/21: Biden Administration Announces Vaccine Mandates for Large Businesses, Health Care Facilities, and Federal Employees (WaPo)

• 9/7/21: 75% of US Adults Have Received at Least One Dose of COVID-19 Vaccine (Bloomberg)

• 9/3/21: CMS Unveils New Guidelines for Medicaid Expansion, COVID-19 Testing, and Vaccine Administration (HealthPayerIntelligence)

• 8/23/21: FDA Grants Full Approval to Pfizer/BioNTech COVID-19 Vaccine (CNN)

• 8/18/21: Biden Administration Recommends Most Americans Get Vaccine Booster 8 Months After Second Shot (NY Times)

• 8/18/21: CDC Releases Studies Showing Declining COVID-19 Vaccine Effectiveness Against Infection (WaPo)

• 8/13/21: CDC Backs Third COVID-19 Vaccine Dose for Some Immunocompromised People (WaPo)

• 8/9/21: US Military Will Require Active-Duty Service Members to Get Vaccinated by September 15 (NY Times)

• 8/6/21: FDA Expected to Authorize COVID-19 Vaccine Boosters for the Immunocompromised (WaPo)

• 8/4/21: Delta Variant Accounts for over 90 Percent of US COVID-19 Cases (The Hill)

• 8/4/21: WHO Calls for Moratorium on COVID-19 Vaccine Boosters (NY Times)

• 8/2/21: US Reaches Milestone of 70% of Adults Receiving at Least One Dose of COVID-19 Vaccine (WaPo)

• 7/27/21: CDC Updates Mask Guidance for Vaccinated People, K-12 Schools (CBS News)

• 7/26/21: Biden Says Long Covid May be Considered a Disability Under Civil Rights Laws (WaPo)

• 7/26/21: VA Issues Vaccine Mandate for Health Care Workers (NY Times)

• 7/26/21: Pfizer and Moderna Expanding Clinical Trials for Children Ages 5-11 at FDA Urging (NY Times)

• 7/22/21: CDC Advisory Panel Urges Guidance on  Vaccine Booster for Immunocompromised People (NBC News)

• 7/22/21: Pfizer, AstraZeneca Vaccines Effective Against COVID-19, UK Study Finds (WaPo)

• 7/20/21: CDC Director: Delta Variant Responsible for 83% of New US Coronavirus Cases (CNN)

• 7/19/21: Federal Judge Upholds Indiana University's Vaccine Requirement for Students (NY Times)

• 7/16/21: CDC Director Warns of Preventable COVID-19 Cases Among Unvaccinated Americans (AP)

• 7/15/21: FDA Official Says EUA for COVID Vaccines for Kids Under 12 Expected Midwinter (NBC)

• 7/15/21: CDC Advisory Panel to Consider Additional COVID-19 Vaccine Dose for Immunocompromised (WaPo)

• 7/12/21: FDA Adds Warning About Increased Risk of Guillain-Barre Syndrome to J&J Vaccine (AP)

• 7/8/21: White House Official Says Nearly All Deaths and Vaccinations Are Among Unvaccinated People (CNBC)

• 7/8/21: Pfizer Plans Clinical Trials for Third Dose of COVID-19 Vaccine to Boost Immunity Against Variants (AP)

• 7/4/21: Biden Urges Americans to Help End COVID-19 Pandemic During July 4 Remarks (Reuters)

• 7/1/21: US to Share Tens of Millions More COVID-19 Vaccine Doses This Summer (CNN)

• 7/1/21: CDC Says 1,000 Counties in the US Have COVID Vaccination Coverage of Less Than 30% (CNBC)

• 6/30/21: Medicaid Beneficiaries Less Likely to Get COVID-19 Shots (RollCall)

• 6/25/21: HHS Pauses Distribution of Eli Lilly's COVID-19 Antibody Treatments Over Efficacy Concerns (Reuters)

• 6/23/21: US to Send 3 Million J&J COVID-19 Vaccine Doses to Brazil (Reuters)

• 6/23/21: CDC Advisory Panel Says COVID-19 Vaccines Linked to Rare, Mild Heart Symptoms (WaPo)

• 6/21/21: Medicaid Enrollment Reaches All-Time High During COVID-19 (WaPo)

• 6/21/21: White House Outlines Plan to Send 55 Million Vaccine Doses to World (NYT)

• 6/17/21: US Health Officials Push for More COVID Vaccinations as Delta Variant Gains Ground (CNBC)

• 6/17/21: US Devotes $3 Billion to Develop Antiviral Medications to Treat COVID-19 (NYT)

• 6/11/21: FDA Approves Two Batches of J&J Vaccine from Baltimore Plant but Says 60 Million Doses Contaminated (WSJ)

• 6/10/21: G7 Nations Pledge 1 Billion Vaccine Doses for World (AP)

• 6/10/21: FDA Extends Expiration Date of J&J Vaccine by 6 Weeks (NYT)

• 6/9/21: Administration Warns Providers and Insurers COVID-19 Vaccines and Testing Must be Free for Patients (NYT)

• 6/4/21: FDA Approves Subcutaneous Injection of Regeneron COVID-19 Antibody Treatment (WSJ)

• 6/3/21: Biden Admin Unveils Plan for Distributing COVID-19 Vaccine to Other Countries (NYT)

• 5/26/21: FDA Authorizes Antibody Treatment for High-Risk COVID-19 Patients (NYT)

• 5/20/21: FDA Allows Longer Refrigerator Storage for Pfizer-BioNTech Vaccine (The Hill)

• 5/14/21: CMS Data Show Vulnerable Americans Forgoing Mental Healthcare During COVID-19 (CMS)

• 5/13/21: Biden Administration Announces $7.4 Billion to Bolster Public Health Workforce (Washington Post)

• 5/13/21: CDC Says Fully Vaccinated No Longer Need Masks in Many Cases (Washington Post)

• 5/12/21: Feds Allocate $6 Billion to Community Health Centers to Address Access Barriers (NYT)

• 5/10/21: FDA Authorizes Pfizer-BioNTech Vaccine for Emergency Use in Adolescents (CNBC)

• 5/5/21: Biden Administration Will Support IP Protections Waiver for COVID-19 Vaccines (NYT)

• 5/3/21: HHS Establishes COVID-19 Coverage Assistance Fund for Vaccination Fees (Bloomberg Law)

• 4/30/21: More Than 100 Million in US Fully Vaccinated Against the Coronavirus (NYT)

• 4/22/21: COVID Outpatients Don’t Benefit From Hydroxychloroquine, Lopinavir-Ritonavir (CIDRAP News)

• 4/14/21: Elderly Show Similar Antibody Response to 1st Dose of Astra, Pfizer COVID-19 Shots — UK Study (Reuters)

• 4/14/21: 1 in 5 Still Say They Won’t Get COVID-19 Vaccine: Poll (The Hill)

• 4/13/21: Pfizer Says It Can Deliver 10% More Vaccine Doses to U.S. by End of May (Axios)

• 4/12/21: Covid-19 Drug Prevents Symptomatic Disease in Study, Regeneron Says (Wall Street Journal)

• 4/12/21: Studies Confirm Racial, Ethnic Disparities In COVID-19 Hospitalizations And Visits (NPR)

• 4/5/21: Researchers Are Hatching a Low-Cost Coronavirus Vaccine (New York Times)

• 4/2/21: Moderna Gets Nod To Speed Up Virus Vaccine Output With Bigger Vials (Reuters)

• 4/1/21: US Draws Close to 100M Vaccinations As Baseball Resumes (AP)

• 4/1/21: NIH To Test Revamped Moderna COVID-19 Vaccine Against South Africa Virus Variant (Becker Hospital Review)

• 3/31/21: Pfizer and BioNTech Say Vaccine Prevents COVID-19 in Adolescents (STAT)

• 3/30/21: Getting One Vaccine Is Good. How About Mix-and-Match? (New York Times

• 3/29/21: Lilly-Vir’s COVID-19 Antibody Combo Reduces Viral Load in Study (Reuters)

• 3/29/21: Pfizer, Moderna COVID-19 Vaccines Highly Effective After First Shot in Real-World Use, U.S. Study Shows (Reuters)

• 3/22/21: AstraZeneca’s COVID-19 Vaccine Is Safe, 79% Effective in Late-Stage U.S. Trials (Wall Street Journal)
• 3/18/21: Johnson & Johnson COVID Vaccine Supply Limited; More Expected in April (Orlando Sentinel
• 3/18/21: Germany, France Among Nations To Resume Use of AstraZeneca Vaccine After Regulators Back Shot (Reuters
• 3/18/21: Existing COVID Vaccines May Protect Against Brazilian Variant — Oxford Study (Reuters)
• 3/18/21: Covid-19 Variant Vaccines in Works at Johnson & Johnson (Wall Street Journal)
• 3/17/21: U.S. Vaccine Production Is Starting To Surge (NBC News)
• 3/17/21: U.S. Falling Short on Vaccine Equity (US News & World Report)
• 3/16/21: FDA Orders COVID Antibody Makers Regeneron, Eli Lilly To Track Virus Variants (Fierce Pharma)
• 3/16/21: GSK Kick-Starts Phase 3 Medicago-Partnered COVID Vaccine Test (Fierce Biotech)

• 3/11/21: Pfizer/BioNTech Say Data Suggests Vaccine 94% Effective in Preventing Asymptomatic Infection (Reuters)

• 3/11/21: Novavax Vaccine 96% Effective Against Original Coronavirus, 86% vs British Variant in UK trial (Reuters)

• 3/8/21:Pfizer/BioNTech COVID-19 Vaccine Neutralizes Brazil Variant in Lab Study (Reuters)

• 3/5/21: FDA Authorizes New Test, Built with Machine Learning, to Detect Past Covid-19 Infections (STAT)

• 3/5/21: Astra Stockpiles Vaccine That Could Speed Up Biden Timeline (Bloomberg)

• 3/5/21: FDA Authorizes Over-The-Counter Coronavirus Test (Axios)

• 3/5/21: Abbott Scores Testing Green Lights for Symptomless COVID-19 Cases, Plus Flu, RSV (Fierce Biotech)

• 3/5/21: FDA Warns Against Using Anti-Parasitic Drug for Covid-19 After Reports of Hospitalizations (CNN)

• 12/11/20: Sanofi and GSK Delay COVID-19 Vaccine, Marking Setback for Global Fight (Reuters)

• 12/11/20: The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020 (CDC)

• 12/10/20: Moderna Begins Study of COVID-19 Vaccine in Adolescents (Reuters)

• 12/9/20: First U.S. Shipments of Pfizer Vaccine Will Be 2.9 Million Doses (Bloomberg)

• 12/9/20: Biden Lays Out Top Three COVID Priorities for First 100 Days (Medscape)

• 12/8/20: Pfizer’s Vaccine Offers Strong Protection After First Dose (New York Times)

• 12/4/20: Vaccine Production in Focus as Moderna, Pfizer Await FDA Decision (BioPharmaDive)

• 12/2/20: CVS, Walgreens Gear Up to Deliver Covid-19 Vaccines to Nursing Homes (Wall Street Journal)

• 11/30/20: ACIP Bumps Up COVID Vax Meeting Timeline (MedPage Today)

• 11/24/20: U.S. Officials Plan to Release 6.4 Million COVID-19 Vaccine Doses in First Distribution (Reuters)

• 11/23/20: ACIP: HCPs, Nursing Home Residents May Get COVID Vax First (MedPage Today)

• 11/23/20: AstraZeneca-Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials (Wall Street Journal)

• 11/19/20: Oxford, AstraZeneca Coronavirus Vaccine’s Strong Response in Elderly Confirmed in Review (Wall Street Journal)

• 11/18/20: Pfizer Says Vaccine Is 95% Effective in Final Data, Will Seek Authorization (Wall Street Journal)

• 11/17/20: J&J Starts Two-Dose Trial of Its COVID-19 Vaccine Candidate (Medscape)

• 11/16/20: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study (Moderna)

• 11/16/20: Pfizer to Start Pilot Delivery Program for its COVID-19 Vaccine in Four U.S. States (Reuters)

• 11/13/20: J&J Taps UnitedHealth to Accelerate Covid-19 Vaccine Trial (Bloomberg)

• 11/12/20: AMA Creates COVID-19 CPT Codes for Pfizer, Moderna Vaccines (Medscape)

• 11/11/20: Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies (PRNewswire)

• 11/09/20: Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective (New York Times)

• 10/30/2020: To Vaccinate Against Covid-19, US Enlists Pharmacy Chains (Wall Street Journal)

• 10/23/2020: Pivotal Studies of Covid-19 Vaccines From AstraZeneca, J&J Resuming (Wall Street Journal)

• 10/22/2020: FDA advisory committee debates safety and efficacy standards for a coronavirus vaccine (Washington Post) 

• 10/20/20: A 'Herculean' Effort: States Finalize Their COVID-19 Vaccine Distribution Plans (USA Today)

• 10/15/20: Pfizer to Start Testing Its Covid-19 Vaccine in Children As Young As 12 (CNN)

• 10/14/20: Johnson & Johnson Pauses COVID-19 Vaccine Trails Due to Sick Subjects (Wall Street Journal)

• 10/06/20: Covid-19 Antibody Drug From Glaxo, Vir Enters Final-Stage Testing (Wall Street Journal)  

• 10/02/20: Diversity Emerges as Key Challenge for Coronavirus Drug Trials (The Hill)

• 09/28/20: Johnson & Johnson COVID-19 Vaccine Produces Strong Immune Response in Early Trials (Reuters)

• 09/28/20: U.S. FDA Pauses Inovio’s Coronavirus Vaccine Trail Plan (Reuters)

• 09/24/20: Researchers Warn Children Not Included in COVID-19 Vaccine Trials (The Hill)

• 9/23/20: Medicare Wouldn’t Cover Costs of Administering Coronavirus Vaccine Approved Under Emergency-Use Authorization (Wall Street Journal)

• 9/23/20: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate (jnj.com)

• 9/23/20: Johnson & Johnson Begins Final-Stage Testing of Covid-19 Vaccine (Wall Street Journal)

• 9/22/20: U.S. Health Agency Sets October 16 Deadline for States to Submit Vaccine Plans (Reuters)

• 9/18/20: How to Ship a Vaccine at –80C, and Other Obstacles in the Covid Fight (New York Times)

• 9/17/20: State Health Authorities Worry About Slow Planning for Covid-19 Vaccine Distribution (Wall Street Journal)

• 9/15/20: Coronavirus Kills Far More Hispanic and Black Children Than White Youths, CDC Study Finds (Washington Post)

• 9/14/20: Pfizer’s COVID-19 Vaccine Could Be Given in Late 2020, CEO Says (Medscape)

• 9/11/:20: Missed Vaccines, Skipped Colonoscopies: Preventive Care Plummets (New York Times)

• 9/10/20: FDA Setting Higher Bar for Emergency Covid Vaccine Clearance (Bloomberg)

• 9/9/20: COVID-19: New Guidance to Stem Mental Health Crisis in Frontline HCPs (Medscape)

• 9/9/20: AstraZeneca Pauses Covid-19 Vaccine Trail After Illness in a U.K. Subject (Wall Street Journal)

• 9/8/20: The Opioid Crisis, Already Serious, Has Intensified During Coronavirus Pandemic (Wall Street Journal)

• 9/4/20: Roche Receives FDA Emergency Use Authorization for the Cobas SARS-CoV-2 & Influenza A/B Test for Use on the Cobas 6800/8800 Systems (Roche.com)

• 9/3/20: Tracing Apps May Stem COVID-19 Spread Even When Only a Few Use Them: Study (Reuters)

• 9/3/20: COVID Convalescent Plasma Guidance Gets EUA Updates (RAPS Regulatory Focus

• 9/2/20: CDC Tells States How to Prepare for Covid-19 Vaccine by Early November (New York Times)

• 8/31/2020: Pharmacies, Not The Military, Will Handle COVID-19 Vaccinations (Axios)

• 8/28/2020: COVID-19 Update: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19 (FDA)

• 8/26/2020: Abbott’s $5 Covid-19 Rapid Antigen Test Gets Emergency-Use Status From FDA (Wall Street Journal)

• 8/13/2020: Covid-19 Vaccines Won’t Come With Copay, US Health Official Says
• 8/11/2020: US inks $1.5 billion deal with Moderna for 100 million doses of COVID-19 vaccine (Reuters)

• 8/7/2020: Vaccine for COVID-19 will need outside expert review, U.S. regulator says (Reuters)

• 8/5/2020: HHS, DOD Collaborate With Johnson & Johnson to Produce Millions of COVID-19 Investigational Vaccine Doses (HHS)

• 8/3/20: Trump Signs Executive Order to Expand Telehealth, Boost Rural Health Care (FierceHealthcare)

• 8/3/20: WHO Chief Warns ‘There Might Never Be’ A Silver Bullet for Coronavirus (NPR) 

• 8/2/20: Birx Warns That U.S. Epidemic is in a ‘New Phase’ (New York Times)

• 8/3/20: Eli Lilly is Testing a Way to Prevent Covid-19 That’s Not a Vaccine (MIT Technology Review)

• 7/31/20: HHS, DOD Partner With Sanofi and GSK on Commercial-Scale Manufacturing Demonstration Project to Produce Millions of COVID-19 Investigational Vaccine Doses (HHS)

• 7/30/20: Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds (New York Times)

• 7/27/20: Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study (Pfizer)
• 7/24/20: The Need to Expand Coverage and Enhance Access to Essential Services on a Pre-deductible Basis Following COVID-19 (JAMA)
• 7/23/20: How Much Will a Coronavirus Vaccine Cost? How Will We Know It's Safe? The Biggest Takeaways From This Week's House Hearing (Advisory Board)
• 7/22/20: Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s End (New York Times)
• 7/21/20: AMA Report Finds Nearly 40% Decline in Opioid Prescriptions, But Overdose Deaths Continue to Climb (FierceHealthcare)
• 7/21/20: Drug Pricing Back in the Spotlight (BioPharm International)
• 7/16/20: Trump Administration Restores Some COVID-19 Hospitalization Data to CDC Website (The Hill)

• 7/14/20: Universal Masking to Prevent SARS-CoV-2 Transmission — The Time is Now (JAMA)

• 7/7/20: School Openings Across Globe Suggest Ways to Keep Coronavirus at Bay, Despite Outbreaks (Science)

• 6/29/20: Gilead Sciences Announces Pricing for COVID-19 Treatment Remdesivir (Pharmacy Times)

• 6/25/20: CDC Updates, Expands List of People at Risk of Severe COVID-19 Illness (CDC)

• 6/25/20: COVID-19 Has Already Cost California Insurers $2.4 Billion, New Study Estimates  (UC Berkeley/Berkeley News)

  6/23/20: COVID-19 May Lead to 10,000 Excess Deaths Due to Breast, Colorectal Cancers (Healio)

• 6/17/20: Part II: De-implementing Low-Value Care Services: Addressing Patient Perspectives (AcademyHealth)

• 6/17/20: ONC Project Aims to Facilitate Real-World Data Access, Exchange (Health IT Analytics)

• 6/15/20: FDA Withdraws Emergency Use Authorization for Hydroxychloroquine (The Hill)  

• 6/11/20: The Next COVID-19 Challenge: Convincing People to get their Flu Shots (The Hill) 

• 6/10/20: During COVID-19 Pandemic Healthcare Professional Revenue Fell Nearly 50% Across Nation (SciTechDaily)

• 6/1/20: Designing Health Plans That Do Not Impede Delivery of High-Value Care (JACC)

• 6/1/20: Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing (GlobeNewswire)

• 6/1/20: COVID-19 Accelerates Non-adherence and Magnifies Health Inequalities (pharmaphorum)

• 5/30/20: The Risks Of Remaining In The Medicare Shared Savings Program During The COVID-19 Pandemic (Health Affairs)

• 5/26/20: Pandemic Pricing: The Risks and Rewards of Fast-Tracking Value-Based Drug Evaluations (Pharmacy Times)

• 5/25/20: WHO Halts Hydroxychloroquine Trial Over Safety Concerns (NPR)
• 5/22/20: Overpriced Drugs Can Harm More Patients Than They Help (ICER)
• 5/21/20: TriNetX & Harvard Pilgrim Health Care Institute Partner on FDA Sentinel System to Monitor COVID-19 Drug Usage (Yahoo Finance)
• 5/21/20: Coronavirus crisis highlights weak links in supply chain for widely used medications (NJ.com)
• 5/20/20: What Health Spending Issues Will We Need To Address Post-Pandemic? (Going Below the Surface/NPC)

• 5/20/20: How Have Health Care Utilization and Spending Changed So Far During the Coronavirus Pandemic? (Kaiser Family Foundation)

• 5/20/20: It’s Time To Talk About COVID-19 Prices (Health Affairs)

• 5/19/20: 12 Things Everyone Needs to Know About the Coronavirus Pandemic (Vox)

• 5/15/20: Less Than a Movie Ticket or ‘Impossible to Overpay’? Experts Name Their Price for Remdesivir (Stat)

• 5/12/20: Waste in COVID-19 Research (BMJ)

• 5/7/20: Pharmacists Play Essential Role in COVID-19 Response (Medical Xpress)

• 5/7/20: Harmonizing Patient-Centered Outcomes and Employer Health Strategies (HR Executive)

• 5/6/20: Interpreting Diagnostic Tests for SARS-CoV-2 (JAMA)

• 5/4/20: Fair Price for Gilead's COVID-19 Med Remdesivir? $4,460, Cost Watchdog Says (Fierce Pharma)

• 5/4/20: Profile of a Killer: the Complex Biology Powering the Coronavirus Pandemic (Nature)

• 5/4/20: NCPDP Issues Updated Guidance on Pharmacy-led COVID Testing (NCPDP)

• 4/30/20: CMS Issues Additional Policy Changes to Address COVID-19, Including Pharmacist Testing (Healthcare Finance News)

• 4/27/20: CARES Act: AMA COVID-19 Pandemic Telehealth Fact Sheet (AMA)

• 4/21/20: Could Tiny Blood Clots Make COVID-19 More Lethal? (HealthDay)
• 4/21/20: Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19 (medRxiv)
• 4/21/20: New U.S. Treatment Guidelines for COVID-19 Don’t See Much Progress (New York Times) 
• 4/20/20: WHO Head Warns Worst of Virus Is Still Ahead (AP)
• 4/20/20: DOJ Clears U.S. Drug Companies To Distribute Hydroxychloroquine To Patients With Coronavirus (Newsweek)
• 4/20/20: Reports Suggest Many Have Had Coronavirus with No Symptoms (AP)
• 4/16/20: Early Peek at Data on Gilead Coronavirus Drug Suggests Patients are Responding to Treatment (STAT)
• 4/16/20: FDA Relaxes Rules to Make Muscle Relaxers, Drugs for Covid-19 (Bloomberg Law)

• 4/15/20: Novo Nordisk Makes Insulin Free for 90 Days to Diabetes Patients Affected by COVID-19 Job Losses  (WRAL TechWire)

• 4/15/20: U.S. Agency Doubles Medicare Payment to $100 for Some COVID-19 Lab Tests (Reuters)
• 4/15/20: Hydroxychloroquine Alleviated Symptoms, Did Not Cure Coronavirus in Small Study (The Hill)
• 4/15/20: Coronavirus sedatives in short supply could be found in states' lethal injection stockpiles, doctors say (Fox Business)
• 4/14/20: FEMA Ships Out Nearly 20 Million Hydroxychloroquine Tablets(Politico)
• 4/13/20: Despite Qualms, Arthritis Drug Is to Be Tested in Coronavirus Study (New York Times)
• 4/12/20: U.S. to Trial Japanese Anti-Flu Drug Avigan for Potential Coronavirus Treatment (Newsweek)
• 4/12/20: Compassionate Use of Remdesivir for Patients with Severe Covid-19 (New England Journal of Medicine)
• 4/10/20: FDA greenlights blood detox device to combat COVID-19's cytokine storms (FierceBiotech)
• 4/10/20: CDC Drops Guidance, Anecdotal Data on Trump-backed Hydroxychloroquine as COVID-19 Treatment (USA Today)
• 4/10/20: ‘There’s a Shortage of Everything’: Pharmacies in New York City Struggle to Keep Key Medications Stocked Amid Coronavirus Outbreak (CNBC)
• 4/3/20: Potential COVID-19 Vaccine Shows Promise in Mouse Study (MedScape)